Akut arter tikanmalarinin rt PA ile trombolitik tedavisi.

Translated title of the contribution: Thrombolysis of acute arterial occlusion with rt PA

M. Kurtoglu, V. Granit, A. Necefli, M. Kurtoglu, R. Güloglu

Research output: Contribution to journalArticle

Abstract

The use of thrombolytic agents to treat peripheral arterial occlusions is a new method. There have been clinical trials with Streptokinase, Urokinase and rt-PA (recombinant tissue plasminogen activator). Despite its advantages, information about complications caused by the use of rt-PA and about its place in treatment is still not complete. And there are not enough studies that are made to form a safe protocol for the use of rt-PA in the treatment of acute peripheral arterial occlusions. The aim of this study was to establish a dose range for rt-PA and to follow the patients with a protocol during and after thrombolysis. Between May 1999 to January 2000, 14 patients with symptoms of pain, poikilothermia, cyanosis and loss of function came to Istanbul Medical Faculty Emergency Surgery Unit. Bolus injection of 5 mgr of rt-PA was followed by 15 minutes of interval. The extent of thrombolysis was checked by angiography and then bolus injection of 5 mgr of rt-PA was repeated. After angiographic control, patients having insufficient thrombolysis, received 0.05 mgr/kg/hour of infusion for 12 hours. At the end of 12 hours, thrombolytic treatment ended with a control angiography. A thromboembolectomy operation was made to patients still having an occlusion after thrombolysis. On the other hand, to avoid re-occlusions, all of the patients received 1.5 mgr/kg/day low molecular weight heparin (enoxyparine).

Original languageUndefined
Pages (from-to)158-162
Number of pages5
JournalUlusal travma dergisi = Turkish journal of trauma & emergency surgery : TJTES
Volume7
Issue number3
StatePublished - 2001
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Angiography
Medical Faculties
Cyanosis
Injections
Streptokinase
Fibrinolytic Agents
Low Molecular Weight Heparin
Urokinase-Type Plasminogen Activator
Hospital Emergency Service
Therapeutics
Clinical Trials
Pain

Cite this

Kurtoglu, M., Granit, V., Necefli, A., Kurtoglu, M., & Güloglu, R. (2001). Akut arter tikanmalarinin rt PA ile trombolitik tedavisi. Ulusal travma dergisi = Turkish journal of trauma & emergency surgery : TJTES, 7(3), 158-162.

Akut arter tikanmalarinin rt PA ile trombolitik tedavisi. / Kurtoglu, M.; Granit, V.; Necefli, A.; Kurtoglu, M.; Güloglu, R.

In: Ulusal travma dergisi = Turkish journal of trauma & emergency surgery : TJTES, Vol. 7, No. 3, 2001, p. 158-162.

Research output: Contribution to journalArticle

Kurtoglu, M, Granit, V, Necefli, A, Kurtoglu, M & Güloglu, R 2001, 'Akut arter tikanmalarinin rt PA ile trombolitik tedavisi.', Ulusal travma dergisi = Turkish journal of trauma & emergency surgery : TJTES, vol. 7, no. 3, pp. 158-162.
Kurtoglu, M. ; Granit, V. ; Necefli, A. ; Kurtoglu, M. ; Güloglu, R. / Akut arter tikanmalarinin rt PA ile trombolitik tedavisi. In: Ulusal travma dergisi = Turkish journal of trauma & emergency surgery : TJTES. 2001 ; Vol. 7, No. 3. pp. 158-162.
@article{a561d06474f9480799205e9cb8b74258,
title = "Akut arter tikanmalarinin rt PA ile trombolitik tedavisi.",
abstract = "The use of thrombolytic agents to treat peripheral arterial occlusions is a new method. There have been clinical trials with Streptokinase, Urokinase and rt-PA (recombinant tissue plasminogen activator). Despite its advantages, information about complications caused by the use of rt-PA and about its place in treatment is still not complete. And there are not enough studies that are made to form a safe protocol for the use of rt-PA in the treatment of acute peripheral arterial occlusions. The aim of this study was to establish a dose range for rt-PA and to follow the patients with a protocol during and after thrombolysis. Between May 1999 to January 2000, 14 patients with symptoms of pain, poikilothermia, cyanosis and loss of function came to Istanbul Medical Faculty Emergency Surgery Unit. Bolus injection of 5 mgr of rt-PA was followed by 15 minutes of interval. The extent of thrombolysis was checked by angiography and then bolus injection of 5 mgr of rt-PA was repeated. After angiographic control, patients having insufficient thrombolysis, received 0.05 mgr/kg/hour of infusion for 12 hours. At the end of 12 hours, thrombolytic treatment ended with a control angiography. A thromboembolectomy operation was made to patients still having an occlusion after thrombolysis. On the other hand, to avoid re-occlusions, all of the patients received 1.5 mgr/kg/day low molecular weight heparin (enoxyparine).",
author = "M. Kurtoglu and V. Granit and A. Necefli and M. Kurtoglu and R. G{\"u}loglu",
year = "2001",
language = "Undefined",
volume = "7",
pages = "158--162",
journal = "Ulusal Travma ve Acil Cerrahi Dergisi",
issn = "1306-696X",
publisher = "Turkish Association of Trauma and Emergency Surgery",
number = "3",

}

TY - JOUR

T1 - Akut arter tikanmalarinin rt PA ile trombolitik tedavisi.

AU - Kurtoglu, M.

AU - Granit, V.

AU - Necefli, A.

AU - Kurtoglu, M.

AU - Güloglu, R.

PY - 2001

Y1 - 2001

N2 - The use of thrombolytic agents to treat peripheral arterial occlusions is a new method. There have been clinical trials with Streptokinase, Urokinase and rt-PA (recombinant tissue plasminogen activator). Despite its advantages, information about complications caused by the use of rt-PA and about its place in treatment is still not complete. And there are not enough studies that are made to form a safe protocol for the use of rt-PA in the treatment of acute peripheral arterial occlusions. The aim of this study was to establish a dose range for rt-PA and to follow the patients with a protocol during and after thrombolysis. Between May 1999 to January 2000, 14 patients with symptoms of pain, poikilothermia, cyanosis and loss of function came to Istanbul Medical Faculty Emergency Surgery Unit. Bolus injection of 5 mgr of rt-PA was followed by 15 minutes of interval. The extent of thrombolysis was checked by angiography and then bolus injection of 5 mgr of rt-PA was repeated. After angiographic control, patients having insufficient thrombolysis, received 0.05 mgr/kg/hour of infusion for 12 hours. At the end of 12 hours, thrombolytic treatment ended with a control angiography. A thromboembolectomy operation was made to patients still having an occlusion after thrombolysis. On the other hand, to avoid re-occlusions, all of the patients received 1.5 mgr/kg/day low molecular weight heparin (enoxyparine).

AB - The use of thrombolytic agents to treat peripheral arterial occlusions is a new method. There have been clinical trials with Streptokinase, Urokinase and rt-PA (recombinant tissue plasminogen activator). Despite its advantages, information about complications caused by the use of rt-PA and about its place in treatment is still not complete. And there are not enough studies that are made to form a safe protocol for the use of rt-PA in the treatment of acute peripheral arterial occlusions. The aim of this study was to establish a dose range for rt-PA and to follow the patients with a protocol during and after thrombolysis. Between May 1999 to January 2000, 14 patients with symptoms of pain, poikilothermia, cyanosis and loss of function came to Istanbul Medical Faculty Emergency Surgery Unit. Bolus injection of 5 mgr of rt-PA was followed by 15 minutes of interval. The extent of thrombolysis was checked by angiography and then bolus injection of 5 mgr of rt-PA was repeated. After angiographic control, patients having insufficient thrombolysis, received 0.05 mgr/kg/hour of infusion for 12 hours. At the end of 12 hours, thrombolytic treatment ended with a control angiography. A thromboembolectomy operation was made to patients still having an occlusion after thrombolysis. On the other hand, to avoid re-occlusions, all of the patients received 1.5 mgr/kg/day low molecular weight heparin (enoxyparine).

UR - http://www.scopus.com/inward/record.url?scp=0035405437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035405437&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 158

EP - 162

JO - Ulusal Travma ve Acil Cerrahi Dergisi

JF - Ulusal Travma ve Acil Cerrahi Dergisi

SN - 1306-696X

IS - 3

ER -